You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hormone Receptor positive

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

Completed
Has Results
  • Breast Cancer Stage IV
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 21, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • (no location specified)
Nov 8, 2022

Hot Flashes, Breast Cancer, Acupuncture Trial in Nanjing (Acupuncture treatment, Sham acupuncture treatment)

Not yet recruiting
  • Hot Flashes
  • +2 more
  • Acupuncture treatment
  • Sham acupuncture treatment
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital of Traditional Chinese Medcine
Nov 11, 2022

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Kansas City, Kansas
  • +2 more
Mar 16, 2023

Hot Flashes, Breast Cancer, Acupuncture Trial in Nanjing (Acupuncture treatment, Sham Acupuncture treatment)

Not yet recruiting
  • Hot Flashes
  • +2 more
  • Acupuncture treatment
  • Sham Acupuncture treatment
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital of Traditional Chinese Medcine
Jul 19, 2022

Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Oct 5, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Hormone Receptor Positive Malignant Tumor of Breast Trial in United States (RAD140)

Completed
  • Hormone Receptor Positive Malignant Neoplasm of Breast
  • New Haven, Connecticut
  • +4 more
Aug 16, 2022

Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer Trial in

Recruiting
  • Hormone Receptor Positive Breast Carcinoma
  • +2 more
  • Chicago, Illinois
  • +2 more
Jul 1, 2022

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Metastatic Breast Cancer Trial (Eftilagimod Alpha, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Aug 2, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)

Not yet recruiting
  • Early-stage Breast Cancer
  • +2 more
  • (no location specified)
Aug 5, 2022

Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Saint Louis, Missouri
  • +1 more
Jul 20, 2022

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Washington, District of Columbia
  • +4 more
Jan 31, 2023

Breast Cancer Trial in Boston (Eribulin Mesylate, Pembrolizumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
Apr 18, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

Recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

Recruiting
  • Early-stage Breast Cancer
  • +6 more
  • Fullerton, California
  • +8 more
Sep 19, 2022

Breast Cancer Female, Hormone-receptor-positive Breast Cancer Trial in Lisboa (Brief Physical Activity Counselling, Structured

Recruiting
  • Breast Cancer Female
  • Hormone-receptor-positive Breast Cancer
  • Brief Physical Activity Counselling
  • Structured Exercise Program
  • Lisboa, Portugal
    Universidade Lusófona, Campo Grande 376
May 5, 2023

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

Active, not recruiting
  • Estrogen Receptor Positive
  • +3 more
  • Radiation Therapy
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 14, 2022